≈ 30 sec
Goal
Step 2
Step 3
Step 4
Step 5

What would you like to do today?

Choose how you'd like to explore the evidence. You can always adjust your selection later.

Thank you for your interest in EBI-ADHD.

Currently, the platform is accessible through participation in an online trial aimed at testing whether the platform improves clinical knowledge. If you take part in the trial, you will be randomly assigned either to use the platform or to a control group. If you are assigned to the control group, you will be given access to the platform after completing the trial (approximately 40 minutes).

The link to take part in the trial will be available over the next few weeks, so please check back again in a few weeks.

Thank you.

We will use your email address only to send you a link to the study and restore your access afterwards. We will not add you to a mailing list or share your address with anyone.

The rest of the website - including information about the platform, how the evidence was developed, and the blog - will remain available.